• Novartis has committed to making a global donation of up to 130 million doses of the anti-malarial drug hydroxychloroquine to support efforts to fight the COVID-19 pandemic.
• Sandoz, the generics and biosimilars division of Novartis, today begins delivering the first doses of hydroxychloroquine to the Swiss authorities, who are organizing its distribution to hospitals.
• Switzerland becomes the first country in Europe, and the second globally after the USA, to receive a donation of this drug.

Rotkreuz, April 3, 2020 – Today, Novartis, …